April 1, 2025 · Form 4 insider transaction
Stone Warren bought 94,518 shares of NeoGenomics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.; On April 1, 2025, Mr. Stone was granted 94,518 stock options. These options vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.